Clinical Oncologist and Researcher at North East Cancer Centre, Health Sciences North. Science fan!
Greater Sudbury / Grand Sudbur
Joined June 2017
- Tweets135
- Following418
- Followers111
- Likes217
Dr. Chen Lee MBO management paradigm at ESMO Gynecological Cancers @StephanieLheur5 @NazlinJivraj
@myESMO
3
38
A great practical presentation on Mirvetuximab in patients with platinum resistant ovarian cancers by my dear colleague馃専 @AinhoaMada @myESMO
@Ilaria_Colombo_ thank you for a compelling discussion of chemoradiotherapy with or without pembrolizumab in patients with high-risk, locally advanced, cervical cancer (KEYNOTE-A18/ENGOT-cx11/GOG-3047): Results for patients enrolled in Asia at @myESMO
2
4
96
I loved Sachia Stonefeld Powell #ASCO2023 #advocate @PowerOvarian insightful presentation on how every patient is 鉁╱nique, the importance of really seeing them in a holistic way and 馃帶馃憘carefully to them.
1
7
201
DESTINY PanTumor02 Phase II trial #ASCO2023 Impressive results for advanced gynecological cancers expressing HER2!
Damage Control: Emerging Therapies for the DDR Pathway. Wonderful poster discussion on Developmental Therapeutics by @StephanieLheur5
1
7
216
CCTG Spring meeting #CCTG2023 Molecular Stratification in gyne malignancies is now the key to get patients better outcomes 馃専
@Ilaria_Colombo_ outstanding discussion on the RUBY Trial: Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer. POSITIVE +++
4
188
Dr Michael A. Bookman excellent keynote talk about critical thinking while incorporating the recent evidence on treatment strategies in gynecological malignancies. Chaired by Dr Domenica Lorusso #myESMO #ESMOGynae23
5
290
New targets for advanced endometrial cancer by Dr Mansoor Mirza @MirzaCPH always a pleasure to learn from you. #myEsmo #ESMOGynae23
6
458
Wonderful educational session by @Ilaria_Colombo_ The evolving ADC treatment landscape in ovarian cancer. This is the future of gynecological malignancies treatment.
7
261
Great satelite session by @AinhoaMada Where are we going with EC? Aiming to improve outcomes in primary advanced or recurrent endometrial cancer with PD-(L)1 inhibitors
Happy to be in beautiful Montreal for the 2022 Canadian Global Oncology Workshop @mcgillu building collaborations to improve equity in global cancer care.
